Weiwei Cui
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
-
- Tryptophan and brain disorders
Papers in
-
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 2
-
- Cancer, Hypoxia, and Metabolism 2
- Cancer, Lipids, and Metabolism 2
- Cancer-related molecular mechanisms research 2
- Cancer Genomics and Diagnostics 1
- Co-authors
- Bo Chu (5 shared papers)Dong Liu (2 shared papers)Wei Gu (2 shared papers)Renjie Chai (1 shared paper)Bin Huang (1 shared paper)Li Yang (1 shared paper)Xiaolong Fu (1 shared paper)Yinghong Yang (1 shared paper)
- Journals
- Molecular Cancer Research (2 papers)Molecular Carcinogenesis (2 papers)Advanced Science (2 papers)Frontiers in Oncology (1 paper)Journal of Pharmacy and Pharmacology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Weiwei Cui
13 papers receiving 348 citations
Weiwei Cui's Hit Papers
Peers
Comparison fields: 5 of 69
- Cancer Research 156
- Biological Psychiatry 20
- Pulmonary and Respiratory Medicine 176
- Molecular Biology 227
- Immunology 40
Countries citing papers authored by Weiwei Cui
This map shows the geographic impact of Weiwei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Cui more than expected).
Fields of papers citing papers by Weiwei Cui
This network shows the impact of papers produced by Weiwei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Cui. The network helps show where Weiwei Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 151 | |
| 2 | Tryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth Hit paper breakdown → | 2023 | 107 |
| 3 | 2023 | 16 | |
| 4 | 2019 | 14 | |
| 5 | 2017 | 13 | |
| 6 | 2021 | 12 | |
| 7 | 2025 | 12 | |
| 8 | 2024 | 11 | |
| 9 | 2019 | 5 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 3 | |
| 12 | 2022 | 2 | |
| 13 | 2024 | 1 |
About Weiwei Cui
Weiwei Cui is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Obstetrics and Gynecology, having authored 13 papers that have together received 351 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Ferroptosis and cancer prognosis (4 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer, Lipids, and Metabolism (2 papers), RNA modifications and cancer (2 papers), Pregnancy and preeclampsia studies (2 papers), Cancer-related molecular mechanisms research (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Cancer Research (156 citations), Biological Psychiatry (20 citations), Pulmonary and Respiratory Medicine (176 citations), Molecular Biology (227 citations) and Immunology (40 citations). Weiwei Cui has collaborated with scholars based in China and United States. Frequent co-authors include Bo Chu, Dong Liu, Wei Gu, Renjie Chai, Bin Huang, Li Yang, Xiaolong Fu, Yinghong Yang, Lutao Du and Yudan Zhang. Their work appears in journals such as Molecular Cancer Research, Molecular Carcinogenesis, Advanced Science, Frontiers in Oncology and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.